New York Times | Biogen Reports Its Alzheimer's Drug Sharply Slowed Cognitive Decline New York Times Aducanumab, which until now has been called BIIB037, is designed to get rid of amyloid plaque in the brain, which is widely believed to be a cause of the dementia in Alzheimer's disease. However, other drugs designed to prevent or eliminate plaque have ... Biogen's Alzheimer's drug slows mental decline in early study Dementia Silver Bullet? New Drug Might Slow Alzheimer's Biogen's Alzheimer's drug shows early promise |